Navigation Links
Pregis Announces First Quarter 2008 Financial Results
Date:5/9/2008

DEERFIELD, Ill., May 9 /PRNewswire/ -- Pregis Corporation, a leading international manufacturer, marketer, and supplier of protective packaging products and specialty packaging solutions, today announced its 2008 first quarter financial results.

For the first quarter of 2008, the Company generated net sales of $259.3 million, an increase of 8.5% over net sales of $239.0 million in the first quarter of 2007. Excluding the impact of favorable foreign currency translation and sales from two acquisitions made in the second half of 2007, the quarter's net sales were down 3% compared to the prior year quarter.

Gross profit margin, as a percent of net sales, was 21.9% in the first quarter of 2008, compared to 25.5% in the first quarter of 2007. The decline in gross margin resulted primarily from significantly increased costs of resin and other raw materials in the 2008 period, which approximated $7 million of year-over-year unfavorability. In order to mitigate these increases in raw material costs, the Company implemented selling price increases throughout its businesses in the first quarter of 2008. However, the Company has experienced a lag in realizing the benefits from these recent price increases relative to the impact of the increased raw material costs, which resulted in the reduction in its gross margin percentage in the first quarter of 2008.

Commenting on the Company's results, Mike McDonnell, President and Chief Executive Officer, stated, "Our first quarter results were negatively impacted by raw material cost inflation, as well as the weakened economic environment in the U.S. as well as in Europe. Although resin costs stabilized somewhat during the first three months of 2008, we expect continued volatility and remain committed to our disciplined focus on achieving pricing for value and full cost recovery as rapidly as possibly. In addition, we continue to drive efficiency initiatives throughout the organization, both to mitigate the
'/>"/>

SOURCE Pregis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Pregis Corporation Appoints New President of Protective Packaging North America
2. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
3. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...kard, from Griffiths School of Nursing and Midwife...the HESTA Australian Nursing Awards. , Professo...patient blood loss during testing procedures, redu...ansfusions among already ill patients. The award w...rnes Crown Entertainment complex. , Nurses rout...
(Date:5/16/2008)...on Public Service Announcement Available, RADNOR,...ition of,National Mental Health Month and Older Pe...n Council (SPC) will offer an important message to...ment. The public service,announcement developed by...o the public health problem of depression and to o...
(Date:5/16/2008)... appointment of Nomura Code Securities Limited as ...r, NEW YORK, May 16 /PRNewswire-FirstCall/ -- Med...ts, Inc. (Amex: MGT ) (the "Company"), and an,ind...Detection (CAD) and,image analysis software which ...sease, today announced the appointment of NM Roths...
(Date:5/16/2008)...16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A.,... Services, was honored by,Executive Women of New J...2008 Awards Dinner. The biennial event, held May 1...ized women of professional distinction in New,Jers...of directors at major,New Jersey-based corporation...
Breaking Medicine News(10 mins):Health News:Research talent wins national Innovation in Nursing award 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
...ntified how depression plays an important role in ...normal heart beats in a depressed person that can ...or for increased risk of death from heart disease....ington University School of Medicine in St. Louis ...
...led sterols might help to lower your "bad" LDL cho... have been shown to block cholesterol's absorption... minimally absorbed by the intestines. The study ...the cases had high cholesterol, and 14 also had ty...
... of ancient Indian exercise and meditation for the... properties and is popularly used to relieve peopl... trauma and anxiety in patients with breast cance...Bangalore Institute of Oncology on Yoga therapy tr...
...nt found in turmeric or curry powder can prevent t... A new study had found that curcumin, a chemical ...that is required for certain forms of cancer to sp...its a protein called nuclear factor-kappa B (NF-kB...
Other Medicine News:Health News:Yoga Can Be Good For Breast Cancer Patients 2
(Date:5/16/2008)... customer thought leaders -, SAN FRANCISCO, May 1...er and trusted resource for clinical trial managem...estigious academic medical centers, research,insti...roup meeting in San,Francisco. The Velos eResearch...ratively manage thousands of clinical trials., Ov...
(Date:5/16/2008)...onstrating that TYKERB and trastuzumab together re...gression-free survival (PFS), -- Combining TYKERB...side of the HER2 receptor may create a more comple...of TYKERB alone despite patients,previous treatme...rapy, LONDON and PHILADELPHIA, May 16 /PRNewswire...
(Date:5/16/2008)...- Veridex, LLC announced today that,its licensing ...ldings,(LabCorp), has commercially launched a new ... assay uses the biological specificity of ,DNA,met...ation of the gene,GST-Pi. Methylation is a modific...dex is developing the methylation markers in this ...
(Date:5/15/2008)...pulation Most Affected by Disease -, WAYNE, N.J. ...ll/ --,Bayer HealthCare Pharmaceuticals, Inc. and ...announced that Nexavar(R) (sorafenib) tablets,sign...t (HR=0.68;,p-value=0.014) in patients in the Asia...noma (HCC), or primary liver cancer versus those,r...
Breaking Medicine Technology:Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 2Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Aspirin like compounds increase insulin secretion in otherwise healthy obese people 17896 1Aspirin like compounds increase insulin secretion in otherwise healthy obese people 17896 2Americans Rank Health Care Near the Top of Their Economic Woes New Poll Finds 17893 1Americans Rank Health Care Near the Top of Their Economic Woes New Poll Finds 17893 2Americans Rank Health Care Near the Top of Their Economic Woes New Poll Finds 17893 3Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A 26M Health Science Center 1915 1Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A 26M Health Science Center 1915 2Springer publishes anthology with the Nanoethics Group 4923 1Springer publishes anthology with the Nanoethics Group 4923 2
...LONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- Ju...AQ: TGEN) today is,reporting data from the dose es...udy of tgAAC94 in patients with inflammatory,arthr... the,University of Washington School of Medicine, ...dish Medical Center, practicing,physician with Sea...
...DGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - Combin... the presentation of,additional data related to it...and CRx-139, at the European League Against,Rheuma...ng, June,13-16, 2007 in Barcelona, Spain., CRx-102...and Chondrocyte,Inflammatory Mediators by CRx-102,...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4
Hemaseel APR a two-component fibrin sealant vapor heated kit, which is the first commercially available fibrin sealant in the United States. Fibrin sealants are used for two specific reasons: to achi
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical
... designed to allow for three-dimensional correctio...e rods with excellent fatigue resistance to provid... system combines a new dimension in flexibility in...nparalleled durability and ease of use when applyi...
Medicine Products: